Development of potential anticancer agents that target the telomere sequence

被引:8
|
作者
Park, Myunji [1 ]
Bruice, Thomas C. [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA
关键词
Telomere; Telomerase; Cancer; DEOXYNUCLEIC GUANIDINE DNG; SOLID-PHASE SYNTHESIS; DEOXYRIBONUCLEIC GUANIDINE; BINDING; LINKAGES; FIDELITY; RNA; HOMOPOLYNUCLEOTIDES; OLIGONUCLEOTIDES; CHROMOSOMES;
D O I
10.1016/j.bmcl.2010.04.089
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The immortality of cancer cells is due to the relatively high concentration of telomerase enzyme that maintains the telomere sequence during cell division. Human telomeric DNA consists of repeats of the sequence d(5'-TTAGGG-3'). Deoxyribonucleic guanidine ( DNG) is a DNA analog in which positively charged guanidine [-NH-C(=NH2+)-NH-] replaces the negatively charged phosphodiester of DNA. The synthesized DNG hexamer AgAgTgCgCpC and dodecamer AgAgTgCgCgCAgAgTgCgCpC are complementary to the non-coding telomere sequence d(5'-TTAGGG-3'). We have found that binding of the complementary DNG hexamer to the telomere is favored over that of DNA telomere by 10(2.5)-fold and binding the dodecamer with 2-mismatched DNA is favored by 10(5)-fold. We have shown that DNG binding to RNA is favored over binding to DNA. A complementary complex of DNG with RNA at the active site of telomerase enzyme would be very stable. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3982 / 3986
页数:5
相关论文
共 50 条
  • [41] Therapeutic potential of thiazolidinediones as anticancer agents
    Panigrahy, D
    Shen, LQ
    Kieran, MW
    Kaipainen, A
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (12) : 1925 - 1937
  • [42] Spiroisobenzofuranone derivatives as potential anticancer agents
    Yin, Chen
    Chen, Peng-Jen
    Chen, Zhe-Sheng
    Stephani, Ralph
    Korlipara, Vijaya
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [43] Alliums as Potential Antioxidants and Anticancer Agents
    Iwar, Kanivalan
    Ochar, Kingsley
    Seo, Yun Am
    Ha, Bo-Keun
    Kim, Seong-Hoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [44] Dietary Antioxidants: Potential Anticancer Agents
    Wu, Xiayu
    Cheng, Jiaoni
    Wang, Xu
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2017, 69 (04): : 521 - 533
  • [45] BET INHIBITORS AS POTENTIAL ANTICANCER AGENTS
    Griguolo, G.
    Stathis, A.
    DRUGS OF THE FUTURE, 2015, 40 (06) : 381 - 388
  • [46] Novel pyrrolomycins as potential anticancer agents
    Liu, Yan
    McGuire, Timothy R.
    Wang, Jian
    Li, Jerry
    Coulter, Don
    Sharp, John
    Cheng, Maosheng
    Li, Rongshi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [47] Benzimidazole Derivatives as Potential Anticancer Agents
    El Rashedy, Ahmed A.
    Aboul-Enein, Hassan Y.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (03) : 399 - 407
  • [48] Diterpenes and Their Derivatives as Potential Anticancer Agents
    Islam, Muhammad Torequl
    PHYTOTHERAPY RESEARCH, 2017, 31 (05) : 691 - 712
  • [49] Telomerase Inhibitors: Potential Anticancer Agents
    Somani, Rakesh R.
    Patel, Mayuri H.
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2016, 13 (01) : 49 - 61
  • [50] Novobiocin Analogs as Potential Anticancer Agents
    Dlugosz, Angelika
    Janecka, Anna
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 728 - 733